Fig. 3From: Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysisForest plots and meta-analyses of studies showing pooled sensitivity (a) and specificity (b) of CAP for detection of ≥S1 steatosis (Stage 0 vs Stage 1–3) in NAFLD patients. c Summary of AUROC of CAP for the diagnosis of ≥S1 steatosis (Stage 0 vs Stage 1–3) in NAFLD patientsBack to article page